2018
DOI: 10.1016/j.msard.2018.03.007
|View full text |Cite
|
Sign up to set email alerts
|

Optical coherence tomography as a biomarker of neurodegeneration in multiple sclerosis: A review

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

1
41
0
1

Year Published

2019
2019
2024
2024

Publication Types

Select...
4
1
1

Relationship

0
6

Authors

Journals

citations
Cited by 69 publications
(48 citation statements)
references
References 57 publications
1
41
0
1
Order By: Relevance
“…In our series, VEP, OCT, and TOS discriminated MS patients with ON from those without it, suggesting that these techniques are sensitive enough to detect structural and/or functional changes produced in the optic nerve after an acute ON episode. However, of the three techniques, OCT yielded the best performance and was the only that could discriminate between MS eyes without a history of ON (nhON group) and healthy controls, as depicted by the ROC curve Thus, our work provides further the evidence that OCT measurements could act as a marker for global axonal damage in visually asymptomatic MS patients (Alonso, Gonzalez-Moron, & Garcea, 2018). Moreover, this was reinforced by the fact that RNFL thickness measurement by OCT correlated with EDSS at baseline.…”
Section: Discussionsupporting
confidence: 54%
See 2 more Smart Citations
“…In our series, VEP, OCT, and TOS discriminated MS patients with ON from those without it, suggesting that these techniques are sensitive enough to detect structural and/or functional changes produced in the optic nerve after an acute ON episode. However, of the three techniques, OCT yielded the best performance and was the only that could discriminate between MS eyes without a history of ON (nhON group) and healthy controls, as depicted by the ROC curve Thus, our work provides further the evidence that OCT measurements could act as a marker for global axonal damage in visually asymptomatic MS patients (Alonso, Gonzalez-Moron, & Garcea, 2018). Moreover, this was reinforced by the fact that RNFL thickness measurement by OCT correlated with EDSS at baseline.…”
Section: Discussionsupporting
confidence: 54%
“…Given the data above, we conclude that OCT, VEP, and TOS may be valid to monitor visual pathway damage in MS patients and that OCT is the most sensitive and specific when compared to the other two. Considering the hypothesis that axonal loss is the predominant cause of disability in MS, it is predicted that RNFL thickness should be smaller in the progressive subtypes of the disease, which has already been shown by several authors (Alonso et al, ; Balk et al, ; Henderson et al, ; Pulicken et al, ; Ratchford et al, ). Interestingly, the rate of RNFL thinning has been found to be greater in active and earlier phases of the disease, which could reflect a plateau effect of advanced stages (Klistorner et al, ; Laron et al, ).…”
Section: Discussionmentioning
confidence: 85%
See 1 more Smart Citation
“…It provides cross-sectional images of the macula and optic nerve head with enough resolution to accurately measure thickness of the individual retinal layers. Degeneration of some of these layers, especially the retinal nerve fiber layer (RNFL, containing the axons of neurons projecting from the retina to the thalamus) and ganglion cell layer (GCL, containing the cell bodies of these neurons), is associated with disease severity and progression in neurodegenerative diseases such as Alzheimer and Parkinson's disease [18,19], but also with neuroaxonal degeneration in multiple sclerosis and amyotrophic lateral sclerosis [20][21][22]. These studies suggest that the neurodegeneration occurs simultaneously in the central nervous system and retina.…”
Section: Introductionmentioning
confidence: 99%
“…If elevated, the mononuclear and total leucocyte cell counts are usually lower than in CNS infections. Optical coherence tomography (OCT) can measure the retinal nerve fiber layer thickness, which is a biomarker for neurodegeneration in MS[34,35].As for body fluid biomarkers other than the abovementioned routine CSF parameters, candidates have classically been identified at protein level, but increased levels of nitric oxide metabolites have also been proposed as disease activity biomarkers[36,37] and the lipid mediatiors 9-hydroxyoctadecadienoic acid (9-HODE) and 13-hydroxyoctadeca-…”
mentioning
confidence: 99%